[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Divis Laboratories Limited - Company Snapshot & SWOT Analysis

June 2019 | 22 pages | ID: DEE52A574A6EN
NAVADHI Market Research Pvt Ltd

US$ 200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The business segments of Divis labs are Active Pharma Ingredients, Nutraceuticals and intermediates. The company exports over 90% of manufactured products to foreign countries and only 8%-10% is consumed in India yearly. The company derives nearly 90% of revenues from developed economies such as Europe and the U.S.

During the period of 2013-2018, the company increased its revenue from INR 25.97 bn to INR 39.49 bn. For the same period, the company has registered an average growth rate of 8.74%.

In 2014 the total revenue of export revenue for Divis Lab was INR 24.02 bn, which increased to INR 34.69 bn in 2018, showing a growth rate of 9.62%. In 2018 the total revenue share of rest of world was 87%.

Scope of the Divis Laboratories Limited - Company Snapshot & SWOT Analysis Report
  • This report provides detailed information about Divis Laboratories Limited including value chain analysis, financial performance, business strategy and SWOT analysis.
  • The report identifies the growth drivers and inhibitors for global pharmaceutical market.
  • This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY

Scope of the Divis Laboratories Limited - Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 Divis Laboratories Limited
  3.1.1 Company Profile
  3.1.2 Divis Laboratories Limited in Pharma Manufacturing Value Chain
  3.1.3 Divis Laboratories: Financial Performance
  3.1.4 Divis Laboratories: Business Strategy
  3.1.5 SWOT Analysis of Divis Laboratories Limited
    Strengths
    Weaknesses
    Opportunities
    Threats

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Orphan Drugs
Biologics and Biosimilars
Current Trends

1. INCREASING SEVERITY OF DRUG PRICE CONTROLS

2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS

3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS

4. INCREASING FOCUS ON CELL THERAPY

5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM

6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS

7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY

Notes
Company Information

LIST OF EXHIBITS

Exhibit 3.1 Key Information of Divis Laboratories Limited
Exhibit 3.2 Contact Information of Divis Laboratories Limited
Exhibit 3.3 Divis Laboratories Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Divis Laboratories Limited Revenue 2013-2018 (in INR billion)
Exhibit 3.5 Year-wise Divis Laboratories Limited Revenue Growth 2014-18 (in %)
Exhibit 3.6 Divis Lab Ltd, Export Revenue (in INR bn)
Exhibit 3.7 Year wise Divis Lab Ltd. Export Revenue Growth (in %)
Exhibit 3.8 Divis Lab Ltd. India Sales Revenue (in INR bn)
Exhibit 3.9 Year wise Divis Lab Ltd. India Sales Revenue growth (in %)
Exhibit 3.10 Source wise Revenue Share of Divis Lab Ltd. (%)
Exhibit 3.11 Source wise Revenue CAGR Growth Forecast for Divis Lab Ltd. 2019-23 (in %)
Exhibit 3.12 Forecast of Divis Lab Ltd. 2019-23 (in INR bn)
Exhibit 3.13 Forecast of Rest of World Revenue for Divis Lab Ltd. 2019-23 (in INR bn)
Exhibit 3.14 Forecast of India Market Revenue for Divis Lab Ltd. 2019-23 (in INR bn)
Exhibit 3.15 Key Products of Divis Laboratories Limited
Exhibit 3.16 SWOT Analysis of Divis Laboratories Limited


More Publications